Literature DB >> 21385772

The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation.

Andreas Goette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21385772     DOI： 10.1093/europace/eur045

Source DB:  PubMed          Journal:  Europace        ISSN： 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  3 in total

Review 1.  Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  J Atr Fibrillation       Date:  2013-08-31

2.  AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population.

Authors:  Sarah C W Marott; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen; Marianne Benn
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 3.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.